en Español Drug Safety Communication (PDF – 59KB) 09-24-2020  FDA Drug Safety Communication The U.S. Food and Drug Administration (FDA) is warning that taking higher than recommended […]

The U.S. Food and Drug Administration (FDA) is warning that hepatitis C treatments Viekira Pak and Technivie can cause serious liver injury mostly in patients with […]

The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction […]

In an effort to reduce the serious risk of infection spread through sharing of multi-dose diabetes pen devices intended for single patient use only, the U.S. […]

To expand therapy options, availability, and access, FDA is: Expanding availability and access to evidence-based treatments for substance use disorders Facilitating development of treatments for substance […]

For Immediate Release: July 12, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Wednesday, […]

On This Page Date: March 30 – 31, 2021 Day1: Tue, Mar 30 9:00 AM – 4:30 PM ET Day2: Wed, Mar 31 9:00 AM – […]

Pharmacy Poisons Board of KenyaNational Drug Authority of Uganda FOR IMMEDIATE RELEASEFriday, July 12, 2024 Unprecedented Multilateral Initiative Brings Focus to the Shared Threat Posed by […]